0001365916-21-000056.txt : 20210804 0001365916-21-000056.hdr.sgml : 20210804 20210804165651 ACCESSION NUMBER: 0001365916-21-000056 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210802 FILED AS OF DATE: 20210804 DATE AS OF CHANGE: 20210804 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Melo John CENTRAL INDEX KEY: 0001501907 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34885 FILM NUMBER: 211144903 MAIL ADDRESS: STREET 1: C/O AMYRIS, INC. STREET 2: 5885 HOLLIS ST., SUITE 100 CITY: EMERYVILLE STATE: CA ZIP: 94608 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AMYRIS, INC. CENTRAL INDEX KEY: 0001365916 STANDARD INDUSTRIAL CLASSIFICATION: INDUSTRIAL ORGANIC CHEMICALS [2860] IRS NUMBER: 550856151 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5885 HOLLIS STREET, SUITE 100 CITY: EMERYVILLE STATE: CA ZIP: 94608 BUSINESS PHONE: 510-450-0761 MAIL ADDRESS: STREET 1: 5885 HOLLIS STREET, SUITE 100 CITY: EMERYVILLE STATE: CA ZIP: 94608 FORMER COMPANY: FORMER CONFORMED NAME: AMYRIS BIOTECHNOLOGIES INC DATE OF NAME CHANGE: 20060613 4 1 wf-form4_162811058889715.xml FORM 4 X0306 4 2021-08-02 0 0001365916 AMYRIS, INC. AMRS 0001501907 Melo John C/O AMYRIS, INC. 5885 HOLLIS STREET, SUITE 100 EMERYVILLE CA 94608 1 1 0 0 President and CEO Performance-based Restricted Stock Units 2021-08-02 4 A 0 6000000 0 A Common Stock 6000000.0 6000000 D Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock. Represents a performance-based restricted stock unit award ("PSU") that vests based on achievement of four specified stock price performance targets over a four-year period, as approved by the Issuer's stockholders at a special meeting on July 26, 2021. Concurrently with this PSU grant, the Reporting Person's 3,250,000 performance-based stock options granted on May 29, 2018 were automatically cancelled in full. /s/ John Melo by Bruna Lawant, Attorney-in-Fact 2021-08-04